These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 20477373)

  • 1. High-throughput and targeted in-depth mass spectrometry-based approaches for biofluid profiling and biomarker discovery.
    Jimenez CR; Piersma S; Pham TV
    Biomark Med; 2007 Dec; 1(4):541-65. PubMed ID: 20477373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum peptidome profiling revealed platelet factor 4 as a potential discriminating Peptide associated with pancreatic cancer.
    Fiedler GM; Leichtle AB; Kase J; Baumann S; Ceglarek U; Felix K; Conrad T; Witzigmann H; Weimann A; Schütte C; Hauss J; Büchler M; Thiery J
    Clin Cancer Res; 2009 Jun; 15(11):3812-9. PubMed ID: 19470732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical perspectives of high-resolution mass spectrometry-based proteomics in neuroscience: exemplified in amyotrophic lateral sclerosis biomarker discovery research.
    Ekegren T; Hanrieder J; Bergquist J
    J Mass Spectrom; 2008 May; 43(5):559-71. PubMed ID: 18416436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein profiling for cancer biomarker discovery using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry and infrared imaging: a review.
    Bakry R; Rainer M; Huck CW; Bonn GK
    Anal Chim Acta; 2011 Mar; 690(1):26-34. PubMed ID: 21414433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enrichment of low-molecular-weight proteins from biofluids for biomarker discovery.
    Chertov O; Simpson JT; Biragyn A; Conrads TP; Veenstra TD; Fisher RJ
    Expert Rev Proteomics; 2005 Jan; 2(1):139-45. PubMed ID: 15966859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of targeted quantitative proteomics analysis in human cerebrospinal fluid using a liquid chromatography matrix-assisted laser desorption/ionization time-of-flight tandem mass spectrometer (LC MALDI TOF/TOF) platform.
    Pan S; Rush J; Peskind ER; Galasko D; Chung K; Quinn J; Jankovic J; Leverenz JB; Zabetian C; Pan C; Wang Y; Oh JH; Gao J; Zhang J; Montine T; Zhang J
    J Proteome Res; 2008 Feb; 7(2):720-30. PubMed ID: 18186601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum proteomics using mass spectrometry.
    Hood BL; Malehorn DE; Conrads TP; Bigbee WL
    Methods Mol Biol; 2009; 520():107-28. PubMed ID: 19381950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Derivatized mesoporous silica beads for MALDI-TOF MS profiling of human plasma and urine.
    Terracciano R; Pasqua L; Casadonte F; Frascà S; Preianò M; Falcone D; Savino R
    Bioconjug Chem; 2009 May; 20(5):913-23. PubMed ID: 19338374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Label-free mass spectrometry-based proteomics for biomarker discovery and validation.
    Pham TV; Piersma SR; Oudgenoeg G; Jimenez CR
    Expert Rev Mol Diagn; 2012 May; 12(4):343-59. PubMed ID: 22616700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mass spectrometry-based clinical proteomics: head-and-neck cancer biomarkers and drug-targets discovery.
    Matta A; Ralhan R; DeSouza LV; Siu KW
    Mass Spectrom Rev; 2010; 29(6):945-61. PubMed ID: 20945361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative profiling of serum glycoproteome by sequential purification of glycoproteins and 2-nitrobenzensulfenyl (NBS) stable isotope labeling: a new approach for the novel biomarker discovery for cancer.
    Ueda K; Katagiri T; Shimada T; Irie S; Sato TA; Nakamura Y; Daigo Y
    J Proteome Res; 2007 Sep; 6(9):3475-83. PubMed ID: 17705522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct tandem mass spectrometry reveals limitations in protein profiling experiments for plasma biomarker discovery.
    Koomen JM; Li D; Xiao LC; Liu TC; Coombes KR; Abbruzzese J; Kobayashi R
    J Proteome Res; 2005; 4(3):972-81. PubMed ID: 15952745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical proteomics in breast cancer: a review.
    Gast MC; Schellens JH; Beijnen JH
    Breast Cancer Res Treat; 2009 Jul; 116(1):17-29. PubMed ID: 19082706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mass spectrometric profiling of low-molecular-weight proteins.
    Rainer M; Sajdik C; Bonn GK
    Methods Mol Biol; 2013; 1023():83-95. PubMed ID: 23765620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Lucid Proteomics System for top-down biomarker research.
    Jourdain S; Bulman A; Dalmasso E
    Arch Physiol Biochem; 2010; 116(4-5):158-62. PubMed ID: 20507259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MSQ: a tool for quantification of proteomics data generated by a liquid chromatography/matrix-assisted laser desorption/ionization time-of-flight tandem mass spectrometry based targeted quantitative proteomics platform.
    Oh JH; Pan S; Zhang J; Gao J
    Rapid Commun Mass Spectrom; 2010 Feb; 24(4):403-8. PubMed ID: 20069694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biomarker discovery for kidney diseases by mass spectrometry.
    Niwa T
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Jul; 870(2):148-53. PubMed ID: 18024247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Developing an integrated proteo-genomic approach for the characterisation of biomarkers for the identification of Bacillus anthracis.
    Misra RV; Ahmod NZ; Parker R; Fang M; Shah H; Gharbia S
    J Microbiol Methods; 2012 Feb; 88(2):237-47. PubMed ID: 22178189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoclonal antibody proteomics: discovery and prevalidation of chronic obstructive pulmonary disease biomarkers in a single step.
    Csanky E; Olivova P; Rajnavolgyi E; Hempel W; Tardieu N; Katalin ET; Jullien A; Malderez-Bloes C; Kuras M; Duval MX; Nagy L; Scholtz B; Hancock W; Karger B; Guttman A; Takacs L
    Electrophoresis; 2007 Dec; 28(23):4401-6. PubMed ID: 18041035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances and challenges in liquid chromatography-mass spectrometry-based proteomics profiling for clinical applications.
    Qian WJ; Jacobs JM; Liu T; Camp DG; Smith RD
    Mol Cell Proteomics; 2006 Oct; 5(10):1727-44. PubMed ID: 16887931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.